Envestnet Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $186K | Sell |
149,741
-13,741
| -8% | -$17K | ﹤0.01% | 4252 |
|
|
2025
Q1 | $193K | Buy |
163,482
+23,359
| +17% | +$27.6K | ﹤0.01% | 4148 |
|
|
2024
Q4 | $256K | Sell |
140,123
-18,047
| -11% | -$33K | ﹤0.01% | 3973 |
|
|
2024
Q3 | $269K | Buy |
158,170
+41,792
| +36% | +$71K | ﹤0.01% | 3881 |
|
|
2024
Q2 | $159K | Sell |
116,378
-9,129
| -7% | -$12.5K | ﹤0.01% | 3986 |
|
|
2024
Q1 | $471K | Sell |
125,507
-3,522
| -3% | -$13.2K | ﹤0.01% | 3477 |
|
|
2023
Q4 | $1.27M | Buy |
129,029
+75,890
| +143% | +$744K | ﹤0.01% | 2756 |
|
|
2023
Q3 | $444K | Buy |
53,139
+18,597
| +54% | +$155K | ﹤0.01% | 3315 |
|
|
2023
Q2 | $459K | Buy |
34,542
+9,936
| +40% | +$132K | ﹤0.01% | 3263 |
|
|
2023
Q1 | $285K | Buy |
24,606
+1,238
| +5% | +$14.3K | ﹤0.01% | 3468 |
|
|
2022
Q4 | $191K | Buy |
23,368
+1,617
| +7% | +$13.2K | ﹤0.01% | 3684 |
|
|
2022
Q3 | $126K | Buy |
21,751
+403
| +2% | +$2.34K | ﹤0.01% | 3696 |
|
|
2022
Q2 | $94K | Buy |
21,348
+1,896
| +10% | +$8.35K | ﹤0.01% | 3761 |
|
|
2022
Q1 | $177K | Sell |
19,452
-573
| -3% | -$5.21K | ﹤0.01% | 3722 |
|
|
2021
Q4 | $410K | Buy |
+20,025
| New | +$410K | ﹤0.01% | 3197 |
|